Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
NORRIS
NORRIS

Norris Medicines Ltd.

BSE: 524414
Sector: Services
15.01+0.0 (+0.07%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
15.01
P/E (TTM)
-
P/B
-
P/S (TTM)
1.98
EV/EBITDA
75.61
CAPE (5Y)
-
ROE (TTM)
-
ROCE (TTM)
2.66
ROA (TTM)
-2.10
Avg 3Y ROE
-
Earnings 3Y CAGR
41.40
Sales 3Y CAGR
-4.10
Sales 5Y CAGR
-7.87
Debt/Equity
-
Consensus TP
-
Strong Buy %
-
Promoter Holding
34.01
Pledged %
0.00

Share Price

Track Norris Medicines Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

15.010.0 (0.07%)
-9.69% in past 1 year
1 Week returns: -2.09 %
Low
14.5
High
16.1
1 Month returns: -23.69 %
Low
14.3
High
20.1
1 Year returns: -9.69 %
Low
12.0
High
20.1
3 Year CAGR: 10.10 %
Low
10.6
High
27.7
5 Year CAGR: 3.71 %
Low
8.1
High
36.8
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Norris Medicines Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Not enough talking points with positive stance
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -2.44% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral
Not enough talking points with neutral stance
Stock in GSM list
The stock has been places in Graded Surveillance Measure (GSM) list (GSM - 0).
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.00175287.

Financial Snapshot

See detailed analysis

Multi-year trends for Norris Medicines Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
00k0k8.4 CrMar 20235.6 CrMar 20245.8 CrMar 20258.1 CrMar 2026
Profit After Tax FY
-0k-0k-0k-0k0-1.7 CrMar 2023-1.2 CrMar 2024-1.2 CrMar 2025-0.3 CrMar 2026
ROE FY
Not enough data
EBITDA FY
-0k00k0k0.9 CrMar 2023-0.2 CrMar 2024-0.3 CrMar 20250.7 CrMar 2026

Norris Medicines Ltd. Shareholding Pattern

Quarterly breakdown of Norris Medicines Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Promoter
10.44
10.44
34.04
34.04
34.04
34.04
34.04
34.04
34.04
34.04
34.04
34.04
34.04
34.01
34.01
34.01
34.01
34.01
34.01
34.00
34.00
34.00
34.00
34.00
34.01
34.01
Indian Promoter
10.44
10.44
34.04
34.04
34.04
34.04
34.04
34.04
34.04
34.04
34.04
34.04
34.04
34.01
34.01
34.01
34.01
34.01
34.01
34.00
34.00
34.00
34.00
34.00
34.01
34.01
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
Mutual Funds / UTI
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
FI/Bank/Insurance
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non-Institution
89.49
89.49
65.89
65.89
65.89
65.89
65.89
65.89
65.89
65.89
65.89
65.89
65.89
65.92
65.92
65.92
65.92
65.92
65.92
65.93
65.93
65.93
65.93
65.93
65.92
65.92
Bodies Corporate
43.99
43.99
43.99
43.99
43.99
43.99
44.00
44.03
44.00
44.00
43.98
43.98
43.98
43.98
43.96
43.96
43.94
43.94
43.94
43.94
43.94
43.92
43.92
43.91
43.91
43.91
Others (incl. Retail)
No. of shareholders
45.50
25,111
45.50
25,092
21.90
25,046
21.90
24,986
21.90
24,930
21.90
24,952
21.89
24,938
21.86
25,060
21.89
25,211
21.89
25,215
21.91
25,252
21.91
25,310
21.91
25,252
21.94
25,182
21.96
25,167
21.96
25,244
21.98
25,445
21.98
25,328
21.98
25,425
21.99
25,587
21.99
25,743
22.01
25,880
22.01
25,825
22.02
25,722
22.01
25,708
22.01
25,708

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Norris Medicines Ltd. shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

Corporate Actions

History of Norris Medicines Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

  1. Others
    Ex-date: 22nd Aug 2013Announced on: 20th Aug 2013
    The existing paid up capital has been reduced by 70 percent as a result every 10 equity shares has been consolidated into 3 equity shares.

Company Profile

Overview of Norris Medicines Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Norris Medicines Limited is an India-based company, which is focused on the health care industry. The Company is engaged in the manufacturing and exporting medicines and injections. The Company’s product categories include antibiotic, anti-inflammatory and analgesic range, G. I. range, dermatologica...
Key personnel
Mr. Iqubal Ismail Patel
Chief Financial Officer
Ms. Priyanka Lohiya
Company Secretary
Mr. Vimal Dhirendra ShahD
Executive Director, Managing Director
Mr. Praveen J. BafnaD
Non-Executive Director
Mr. Angamuthu VadivelD
Non-Executive Independent Director
Ms. Sathya VenkatachalamD
Non-Executive Independent Director
Incorporated on
07 Sep 1990
Last Annual
31 Mar 2026
Last Interim
30 Jun 2026
No. of Employees
18
IPO date
15 Dec 1993
Free Float
9,24,06,170
Phone no.
+912646223462
Address
Plot No. 801/P, 901/3-5 GIDC Industrial Estate, ANKLESHWAR, 393002, India

Frequently Asked Questions

What is the current share price of Norris Medicines Ltd.?
The current share price of Norris Medicines Ltd. is ₹ 15.01 as of 23 Oct 2026.
What is the market capitalisation of Norris Medicines Ltd.?
The market capitalisation of Norris Medicines Ltd. stands at ₹ 15.01 Cr.
What is the PE ratio of Norris Medicines Ltd.?
The Price-to-Earnings (PE) ratio of Norris Medicines Ltd. is - as of the latest trailing twelve months data.
What is the ROE and ROCE of Norris Medicines Ltd.?
Norris Medicines Ltd. has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of 2.66% as per the latest financial reports.
What is the 52-week high and low of Norris Medicines Ltd.?
The 52-week high of Norris Medicines Ltd. is - and the 52-week low is -.
What is the dividend yield of Norris Medicines Ltd.?
The dividend yield of Norris Medicines Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Norris Medicines Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.07% and retail/public investors hold 22.01% of Norris Medicines Ltd. shares.
What sector does Norris Medicines Ltd. belong to?
Norris Medicines Ltd. operates in the Services sector.
What is the beta of Norris Medicines Ltd.?
The beta of Norris Medicines Ltd. is 0.28, indicating its price volatility relative to the broader market. Over the past 1 year, Norris Medicines Ltd. has delivered an absolute return of -5.78%.
What is the RSI of Norris Medicines Ltd.?
The 14-day Relative Strength Index (RSI) of Norris Medicines Ltd. is 41.10, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.